89bio Inc

NASDAQ:ETNB 11:18:07 AM EDT

15.37

+0.48 (+3.22%)

89bio Inc Stock, NASDAQ:ETNB

142 Sansome Street, 2nd floor, San Francisco, California 94104

United States of America

Phone: +1.415.432.9270

Number of Employees: 45

http://www.89bio.com

Description

89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded in January 2018 and is headquartered in San Francisco, CA.